The goal of induction of labor is to achieve vaginal delivery by
stimulating uterine contractions before the spontaneous onset of
labor. According to the National Center for Health Statistics,
the overall rate of induction of labor in the United States has
increased from 90 per 1,000 live births in 1989 to 184 per 1,000
live births in 1997 (1). Generally, induction of labor has merit
as a therapeutic option when the benefits of expeditious
delivery outweigh the risks of continuing the pregnancy. The
benefits of labor induction must be weighed against the
potential maternal or fetal risks associated with this
procedure. The purpose of this bulletin is to review current
methods for cervical ripening and induction of labor and to
summarize the effectiveness of these approaches based on
appropriately conducted outcomes-based research. These practice
guidelines classify the indications for and contraindications to
induction of labor, describe the various agents used for
cervical ripening, cite methods used to induce labor, and
outline the requirements for the safe clinical use of the
various methods of inducing labor.
Background
In 1948, Theobald and associates described their use of the
posterior pituitary extract, oxytocin, by intravenous drip for
labor induction (2). Five years later, oxytocin was the first
polypeptide hormone synthesized by du Vigneaud and associates
(3). This synthetic polypeptide hormone has since been used to
stimulate uterine contractions. Other methods used for induction
of labor include membrane stripping, amniotomy, and
administering prostaglandin E (PGE) analogues.
Cervical Ripening
If induction is indicated and the status of the cervix is
unfavorable, agents for cervical ripening may be used. The
status of the cervix can be determined by the Bishop pelvic
scoring system (Table 1) (4). If the total score is more than 8,
the probability of vaginal delivery after labor induction is
similar to that after spontaneous labor.
Acceptable methods for cervical ripening include mechanical
cervical dilators and administration of synthetic prostaglandin
E1 (PGE1) and prostaglandin E2 (PGE2) (5-9). Mechanical dilation
methods are effective in ripening the cervix and include
hygroscopic dilators, osmotic dilators (Laminaria japonicum),
the 24-French Foley balloon, and the double balloon device (Atad
Ripener Device) (10-15). Laminaria ripen the cervix but may be
associated with increased peripartum infections (6, 16).
|
Table 1. Bishop Scoring System |
|
Factor |
|
Score |
Dilation (cm) |
Effacement (%) |
Station* |
Cervical Consistency |
Position of Cervix |
|
0 |
Closed |
0-30 |
-3 |
Firm |
Posterior |
|
1 |
1-2 |
40-50 |
-2 |
Medium |
Midposition |
|
2 |
3-4 |
60-70 |
-1,0 |
Soft |
Anterior |
|
3 |
5-6 |
80 |
+1,+2 |
-- |
-- |
|
*Station reflects a . 3 to +3 scale. |
|
Modified from Bishop EH. Pelvic scoring for elective
induction. Obstet Gynecol 1964;24:267 |
Misoprostol, a synthetic PGE1 analogue, can be administered
intravaginally or orally and is used for both cervical ripening
and induction. It currently is available as a 100-mcg or 200-mcg
tablet, and can be broken to provide 25-mcg or 50-mcg doses.
Misoprostol currently is approved by the U.S. Food and Drug
Administration (FDA) for the prevention of peptic ulcers, but
not for cervical ripening or induction of labor.
Two PGE2 preparations are commercially available: a gel
available in a 2.5-mL syringe containing 0.5 mg of dinoprostone
and a vaginal insert containing 10 mg of dinoprostone. Both are
approved by the FDA for cervical ripening in women at or near
term. The vaginal insert releases prostaglandin (PG) at a slower
rate (0.3 mg/h) than the gel. Both the gel and the vaginal
insert have been reported to increase the probability of
successful initial induction, shorten the interval from
induction to delivery, and decrease the total and maximal doses
of oxytocin needed to induce contractions (17).
Other pharmacologic methods for cervical ripening include
continuous intravenous oxytocin drip, extraamniotic saline
infusion, vaginal recombinant human relaxin, and intracervical
purified porcine relaxin. The safety and efficacy of these
latter methods are unclear.
Methods of Labor Induction
In addition to oxytocin and misoprostol, other agents can be
used for induction of labor. The progesterone antagonist
mifepristone (RU 486) is one such suitable and effective
induction agent (18). Nonpharmacologic methods of labor
induction include stripping the amniotic membranes, amniotomy,
and nipple stimulation.
Confirmation of Term Gestation
- Fetal heart tones have been documented for 20
weeks by nonelectronic fetoscope or for 30 weeks by
Doppler.
- It has been 36 weeks since a positive serum or
urine human chorionic gonadotropin pregnancy test
was performed by a reliable laboratory.
- An ultrasound measurement of the crown. rump
length, obtained at 6-12 weeks, supports a
gestational age of at least 39 weeks.
- An ultrasound obtained at 13-20 weeks confirms
the gestational age of at least 39 weeks determined
by clinical history and physical examination.
|
Oxytocin
Oxytocin, an octapeptide, is one of the most commonly used
drugs in the United States. The physiology of
oxytocin-stimulated labor is similar to that of spontaneous
labor, although individual patients vary in sensitivity and
response to oxytocin. Based on pharmacokinetic studies of
synthetic oxytocin, uterine response ensues after 3-5 minutes of
infusion, and a steady state of oxytocin is achieved in plasma
by 40 minutes (19). The uterine response to oxytocin depends on
the duration of the pregnancy; there is a gradual increase in
response from 20 to 30 weeks of gestation, followed by a plateau
from 34 weeks of gestation until term, when sensitivity
increases (20). Cervical dilation, parity, and gestational age
are predictors of the dose response to oxytocin for labor
stimulation (21).
Membrane Stripping
Stripping the amniotic membranes is commonly practiced to
induce labor. However, several studies have yielded conflicting
results regarding the efficacy of membrane stripping (22-24).
Significant increases in phospholipase A2 activity and
prostaglandin F2a (PGF2a) levels occur from membrane stripping
(25). Stripping membranes appears to be associated with a
greater frequency of spontaneous labor and fewer inductions for
postterm pregnancy. In a randomized trial of 195 normal
pregnancies beyond 40 weeks of gestation, two thirds of the
patients who underwent membrane stripping labored spontaneously
within 72 hours, compared with one third of the patients who
underwent examination only (26).
Amniotomy
Artificial rupture of the membranes may be used as a method
of labor induction, especially if the condition of the cervix is
favorable. Used alone for inducing labor, amniotomy can be
associated with unpredictable and sometimes long intervals
before the onset of contractions. However, in a trial of
amniotomy combined with early oxytocin infusion compared with
amniotomy alone, the induction-to-delivery interval was shorter
with the amniotomy-plus-oxytocin method (27).
What are the indications and contraindications to
induction of labor?
Indications for induction of labor are not absolute but
should take into account maternal and fetal conditions,
gestational age, cervical status, and other factors. Following
are examples of maternal or fetal conditions that may be
indications for induction of labor:
- Abruptio placentae
- Chorioamnionitis
- Fetal demise
- Pregnancy-induced hypertension
- Premature rupture of membranes
- Postterm pregnancy
- Maternal medical conditions (eg, diabetes mellitus,
renal disease, chronic pulmonary disease, chronic
hypertension)
- Fetal compromise (eg, severe fetal growth restriction,
isoimmunization)
- Preeclampsia, eclampsia
Labor also may be induced for logistic reasons, for example,
risk of rapid labor, distance from hospital, or psychosocial
indications. In such circumstances, at least one of the criteria
in the box should be met or fetal lung maturity should be
established (28).
Generally, the contraindications to labor induction are the
same as those for spontaneous labor and vaginal delivery. They
include, but are not limited to, the following situations:
- Vasa previa or complete placenta previa
- Transverse fetal lie
- Umbilical cord prolapse
- Previous transfundal uterine surgery
However, the individual patient and clinical situation should be
considered in determining when induction of labor is
contraindicated. Several obstetric situations are not
contraindications to the induction of labor but do necessitate
special attention. These include, but are not limited to, the
following:
- One or more previous low-transverse cesarean deliveries
- Breech presentation
- Maternal heart disease
- Multifetal pregnancy
- Polyhydramnios
- Presenting part above the pelvic inlet
- Severe hypertension
- Abnormal fetal heart rate patterns not necessitating
emergent delivery